{"id":"https://openalex.org/W71889116","doi":"https://doi.org/10.2741/a730","title":"T-lymphocyte epitope identification and their use in vaccine development for HIV-1","display_name":"T-lymphocyte epitope identification and their use in vaccine development for HIV-1","publication_year":2002,"publication_date":"2002-01-01","ids":{"openalex":"https://openalex.org/W71889116","doi":"https://doi.org/10.2741/a730","mag":"71889116","pmid":"https://pubmed.ncbi.nlm.nih.gov/12048179"},"language":"en","primary_location":{"id":"doi:10.2741/a730","doi":"https://doi.org/10.2741/a730","is_oa":true,"landing_page_url":"https://doi.org/10.2741/a730","pdf_url":"https://www.imrpress.com/journal/FBL/7/4/10.2741/A730/pdf","source":{"id":"https://openalex.org/S185455647","display_name":"Frontiers in bioscience","issn_l":"1093-4715","issn":["1093-4715","1093-9946","1094-3935"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-70"],"host_organization":"https://openalex.org/P4310320848","host_organization_name":"Frontiers in Bioscience","host_organization_lineage":["https://openalex.org/P4310320848"],"host_organization_lineage_names":["Frontiers in Bioscience"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Bioscience","raw_type":"journal-article"},"volume":null,"type":"review","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.imrpress.com/journal/FBL/7/4/10.2741/A730/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5088019995","display_name":"Mark J. Newman","orcid":"https://orcid.org/0000-0002-0433-6690","observed_orcids":["https://orcid.org/0000-0002-0433-6690"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Mark J Newman","raw_affiliation_strings":["Epimmune Inc., 5820 Nancy Ridge Drive, San Diego, CA 92121, USA. mnewman@epimmune.com","Epimmune Inc., 5820 Nancy Ridge Drive, San Diego, CA 92121, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Epimmune Inc., 5820 Nancy Ridge Drive, San Diego, CA 92121, USA. mnewman@epimmune.com","institution_ids":[]},{"raw_affiliation_string":"Epimmune Inc., 5820 Nancy Ridge Drive, San Diego, CA 92121, USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5088019995"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0473,"has_fulltext":true,"cited_by_count":15,"citation_normalized_percentile":{"value":0.06666667,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":96},"biblio":{"volume":"7","issue":"4","first_page":"d1503","last_page":"1515"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.9291999936103821,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.9291999936103821,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12576","display_name":"vaccines and immunoinformatics approaches","score":0.05999999865889549,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.007400000002235174,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hiv-1","display_name":"HIV-1","score":0.8510000109672546},{"id":"https://openalex.org/keywords/epitope-identification","display_name":"epitope identification","score":0.8410000205039978},{"id":"https://openalex.org/keywords/ctl-epitopes","display_name":"CTL epitopes","score":0.8069999814033508},{"id":"https://openalex.org/keywords/helper-t-cell-epitopes","display_name":"helper T cell epitopes","score":0.8669999837875366},{"id":"https://openalex.org/keywords/hiv-1-vaccine-development","display_name":"HIV-1 vaccine development","score":0.8080000281333923},{"id":"https://openalex.org/keywords/dna-vaccine","display_name":"DNA vaccine","score":0.7720000147819519},{"id":"https://openalex.org/keywords/cell-mediated-immunity","display_name":"cell-mediated immunity","score":0.6539999842643738},{"id":"https://openalex.org/keywords/epitope-dominance","display_name":"epitope dominance","score":0.7360000014305115},{"id":"https://openalex.org/keywords/conserved-epitopes","display_name":"conserved epitopes","score":0.7549999952316284}],"concepts":[{"id":"https://openalex.org/C195616568","wikidata":"https://www.wikidata.org/wiki/Q128711","display_name":"Epitope","level":3,"score":0.9753087759017944},{"id":"https://openalex.org/C147969180","wikidata":"https://www.wikidata.org/wiki/Q5014579","display_name":"CTL*","level":4,"score":0.8947252035140991},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.6249075531959534},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.6094451546669006},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5816695690155029},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.5574373602867126},{"id":"https://openalex.org/C2778886782","wikidata":"https://www.wikidata.org/wiki/Q536541","display_name":"Subdominant","level":4,"score":0.5326385498046875},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.46629732847213745},{"id":"https://openalex.org/C2780195530","wikidata":"https://www.wikidata.org/wiki/Q1479804","display_name":"HIV vaccine","level":4,"score":0.4323861300945282},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.40403133630752563},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.36906787753105164},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.3659743666648865},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.3256192207336426},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.2640678286552429},{"id":"https://openalex.org/C2778190748","wikidata":"https://www.wikidata.org/wiki/Q7907956","display_name":"Vaccine trial","level":3,"score":0.0},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006377","descriptor_name":"T-Lymphocytes, Helper-Inducer","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013602","descriptor_name":"T-Lymphocytes, Cytotoxic","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D015497","descriptor_name":"HIV-1","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D016176","descriptor_name":"T-Lymphocyte Subsets","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D016915","descriptor_name":"AIDS Vaccines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D018984","descriptor_name":"Epitopes, T-Lymphocyte","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.2741/a730","doi":"https://doi.org/10.2741/a730","is_oa":true,"landing_page_url":"https://doi.org/10.2741/a730","pdf_url":"https://www.imrpress.com/journal/FBL/7/4/10.2741/A730/pdf","source":{"id":"https://openalex.org/S185455647","display_name":"Frontiers in bioscience","issn_l":"1093-4715","issn":["1093-4715","1093-9946","1094-3935"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-70"],"host_organization":"https://openalex.org/P4310320848","host_organization_name":"Frontiers in Bioscience","host_organization_lineage":["https://openalex.org/P4310320848"],"host_organization_lineage_names":["Frontiers in Bioscience"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Bioscience","raw_type":"journal-article"},{"id":"pmid:12048179","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12048179","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in bioscience : a journal and virtual library","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.2741/a730","doi":"https://doi.org/10.2741/a730","is_oa":true,"landing_page_url":"https://doi.org/10.2741/a730","pdf_url":"https://www.imrpress.com/journal/FBL/7/4/10.2741/A730/pdf","source":{"id":"https://openalex.org/S185455647","display_name":"Frontiers in bioscience","issn_l":"1093-4715","issn":["1093-4715","1093-9946","1094-3935"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-70"],"host_organization":"https://openalex.org/P4310320848","host_organization_name":"Frontiers in Bioscience","host_organization_lineage":["https://openalex.org/P4310320848"],"host_organization_lineage_names":["Frontiers in Bioscience"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Bioscience","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.8560000061988831,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1620723082","display_name":"DEVELOPMENT OF PEPTIDE-BASED IMMUNOTHERAPEUTIC FOR AIDS","funder_award_id":"U19AI038584","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G2091366742","display_name":"EPITOPE BASED DNA VACCINES FOR AIDS THERAPY","funder_award_id":"P01AI048238","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G7429760988","display_name":null,"funder_award_id":"AI38584","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G7464954056","display_name":null,"funder_award_id":"AI48238","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337355","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W71889116.pdf","grobid_xml":"https://content.openalex.org/works/W71889116.grobid-xml"},"referenced_works_count":110,"referenced_works":["https://openalex.org/W60866071","https://openalex.org/W1481708591","https://openalex.org/W1504316996","https://openalex.org/W1512441015","https://openalex.org/W1522645228","https://openalex.org/W1544140174","https://openalex.org/W1566941893","https://openalex.org/W1570526167","https://openalex.org/W1574561647","https://openalex.org/W1578943666","https://openalex.org/W1581580944","https://openalex.org/W1599172762","https://openalex.org/W1601810440","https://openalex.org/W1646416275","https://openalex.org/W1655510925","https://openalex.org/W1664856171","https://openalex.org/W1675195038","https://openalex.org/W1815763197","https://openalex.org/W1929658082","https://openalex.org/W1944657476","https://openalex.org/W1965435557","https://openalex.org/W1967582433","https://openalex.org/W1969057879","https://openalex.org/W1969133711","https://openalex.org/W1971321663","https://openalex.org/W1973012987","https://openalex.org/W1975184547","https://openalex.org/W1980744280","https://openalex.org/W1981323631","https://openalex.org/W1982752226","https://openalex.org/W1986050959","https://openalex.org/W1988136894","https://openalex.org/W1990768351","https://openalex.org/W1990806106","https://openalex.org/W1991731171","https://openalex.org/W1992039355","https://openalex.org/W1993096398","https://openalex.org/W2001079898","https://openalex.org/W2002491652","https://openalex.org/W2011646391","https://openalex.org/W2014970786","https://openalex.org/W2019993505","https://openalex.org/W2026615262","https://openalex.org/W2027288475","https://openalex.org/W2027795203","https://openalex.org/W2031477951","https://openalex.org/W2032598206","https://openalex.org/W2035620466","https://openalex.org/W2037343680","https://openalex.org/W2040381923","https://openalex.org/W2041553413","https://openalex.org/W2045820973","https://openalex.org/W2046238191","https://openalex.org/W2049369627","https://openalex.org/W2054617766","https://openalex.org/W2054901286","https://openalex.org/W2066493864","https://openalex.org/W2068193367","https://openalex.org/W2071798673","https://openalex.org/W2072865691","https://openalex.org/W2075820422","https://openalex.org/W2076058809","https://openalex.org/W2078113755","https://openalex.org/W2079129173","https://openalex.org/W2079176471","https://openalex.org/W2080956086","https://openalex.org/W2080980504","https://openalex.org/W2082296437","https://openalex.org/W2095575390","https://openalex.org/W2096677017","https://openalex.org/W2098209230","https://openalex.org/W2099028937","https://openalex.org/W2101340968","https://openalex.org/W2103059036","https://openalex.org/W2103182811","https://openalex.org/W2105217328","https://openalex.org/W2105541213","https://openalex.org/W2107857115","https://openalex.org/W2108381430","https://openalex.org/W2108445163","https://openalex.org/W2108680356","https://openalex.org/W2112184010","https://openalex.org/W2113983720","https://openalex.org/W2117189753","https://openalex.org/W2119197572","https://openalex.org/W2119701407","https://openalex.org/W2129114331","https://openalex.org/W2129550844","https://openalex.org/W2143329914","https://openalex.org/W2149729349","https://openalex.org/W2149865787","https://openalex.org/W2151527117","https://openalex.org/W2153131265","https://openalex.org/W2162969248","https://openalex.org/W2163004954","https://openalex.org/W2163678116","https://openalex.org/W2166831581","https://openalex.org/W2166883229","https://openalex.org/W2170303823","https://openalex.org/W2171499092","https://openalex.org/W2171656250","https://openalex.org/W2178523848","https://openalex.org/W2320498484","https://openalex.org/W2320993872","https://openalex.org/W2327503296","https://openalex.org/W2330056188","https://openalex.org/W2463162684","https://openalex.org/W4248573432","https://openalex.org/W4251258280","https://openalex.org/W4313347659"],"related_works":["https://openalex.org/W2504417067","https://openalex.org/W2437178430","https://openalex.org/W2150408362","https://openalex.org/W2006291622","https://openalex.org/W2608551172","https://openalex.org/W2908812116","https://openalex.org/W2909813352","https://openalex.org/W2416888738","https://openalex.org/W2276107275","https://openalex.org/W1977768693"],"abstract_inverted_index":{"Cellular":[0],"immune":[1,109,124],"responses":[2,36,110],"mediated":[3],"by":[4],"CD8+":[5],"cytotoxic":[6],"T-lymphocytes":[7,12],"(CTL)":[8],"and":[9,19,34,44,47,56,130,139,180,191],"CD4+":[10],"helper":[11],"(HTL)":[13],"are":[14,37,73,144,204],"needed":[15],"to":[16,69,122,147,165,170,176,187],"effectively":[17],"control":[18],"clear":[20],"many":[21],"viral":[22,80,93],"pathogens,":[23],"including":[24],"HIV-1.":[25],"Thus,":[26],"vaccines":[27,60,159],"for":[28,208],"HIV-1":[29,134],"capable":[30],"of":[31,41,52,79,126,194,199],"inducing":[32],"CTL":[33,55,131,200],"HTL":[35,57,129,202],"now":[38,205],"the":[39,77,106,163,172,189],"focus":[40],"multiple":[42,92],"academic":[43],"industry-based":[45],"research":[46],"development":[48],"programs.":[49],"The":[50],"use":[51,70,150],"defined,":[53],"minimal":[54],"epitopes":[58,71,90,118,132,161,186,203],"in":[59,102,141,151],"has":[61],"several":[62],"potential":[63],"advantages.":[64],"Firstly,":[65],"it":[66],"is":[67],"possible":[68],"that":[72,143],"conserved":[74],"thus":[75],"targeting":[76,168],"majority":[78],"variants":[81],"within":[82],"a":[83],"given":[84],"clade":[85],"or":[86,95,201],"across":[87],"clades.":[88],"Secondly,":[89],"from":[91,133],"structural":[94],"accessory":[96],"gene":[97,174],"products":[98,175],"can":[99,119],"be":[100,120],"included":[101],"vaccines,":[103],"which":[104],"supports":[105],"induction":[107],"cellular":[108,178],"with":[111,156],"significant":[112],"breadth.":[113],"Finally,":[114],"dominance":[115],"relationships":[116],"between":[117,185],"altered":[121],"increase":[123],"recognition":[125],"subdominant":[127],"epitopes.":[128,196],"have":[135],"recently":[136],"been":[137],"identified":[138],"characterized":[140],"numbers":[142],"large":[145],"enough":[146],"support":[148],"their":[149],"experimental":[152],"vaccines.":[153],"Initial":[154],"studies":[155],"prototype":[157],"DNA":[158],"encoding":[160],"indicate":[162],"need":[164],"include":[166],"intracellular":[167],"sequences,":[169],"direct":[171],"encoded":[173],"different":[177],"compartments,":[179],"amino":[181],"acid":[182],"spacer":[183],"sequences":[184],"optimize":[188],"processing,":[190],"subsequent":[192],"presentation,":[193],"individual":[195],"Vaccines":[197],"composed":[198],"being":[206],"developed":[207],"clinical":[209],"testing.":[210]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2020,"cited_by_count":2},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}